China Digest: Sequoia China leads funding in Ubras; Hillhouse invests $14m in WeMed

Ubras has raised “tens of millions of US dollars” in a Series B+ round led by Sequoia Capital China, while Beijing WeMed Medical Equipment has bagged 100 million yuan ($14 million) in a Series C+ round from Hillhouse Capital.